Corrigendum to "Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis" [Clin. Immunol. 288 (2026) 110766].
- DOI
- 10.1016/j.clim.2026.110778
- Published
- 2026 Sep 13
- Container
- Clinical immunology (Orlando, Fla.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clim.2026.110778,
title = {Corrigendum to "Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis" [Clin. Immunol. 288 (2026) 110766].},
author = {Okuda DT and Anderson BJ and Taylor SM and Jones-McCreary MC and Burgess KW and Wright CM and Santoyo JR and Sguigna PV and Stüve O and Tran DH and Light DY and Moog TM and Punnen TG},
year = {2026},
journal = {Clinical immunology (Orlando, Fla.)},
doi = {10.1016/j.clim.2026.110778},
url = {https://doi.org/10.1016/j.clim.2026.110778}
}RIS
TY - JOUR TI - Corrigendum to "Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis" [Clin. Immunol. 288 (2026) 110766]. AU - Okuda DT AU - Anderson BJ AU - Taylor SM AU - Jones-McCreary MC AU - Burgess KW AU - Wright CM AU - Santoyo JR AU - Sguigna PV AU - Stüve O AU - Tran DH AU - Light DY AU - Moog TM AU - Punnen TG PY - 2026 JO - Clinical immunology (Orlando, Fla.) DO - 10.1016/j.clim.2026.110778 UR - https://doi.org/10.1016/j.clim.2026.110778 ER -
APA
DT, O., BJ, A., SM, T., MC, J., KW, B., CM, W., JR, S., PV, S., O, S., DH, T., DY, L., TM, M., & TG, P. (2026). Corrigendum to "Comparative multi-analyte serum protein differences between generic and brand-name dimethyl fumarate, fingolimod, and teriflunomide in multiple sclerosis" [Clin. Immunol. 288 (2026) 110766].. Clinical immunology (Orlando, Fla.). https://doi.org/10.1016/j.clim.2026.110778
Source records
- pubmed · retrieved 2026-09-25T10:35:48.227Z